<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9049">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05706337</url>
  </required_header>
  <id_info>
    <org_study_id>YXLL-KY-2022(060)</org_study_id>
    <nct_id>NCT05706337</nct_id>
  </id_info>
  <brief_title>Clinical Observation of Ciprofol for Anesthesia Induction</brief_title>
  <official_title>Clinical Observation of Ciprofol for Anesthesia Induction in the Elderly Undergoing Elective Non-cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiumei Song</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qianfoshan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of ciprofol anesthesia Induction on hemodynamics in elderly patients&#xD;
      undergoing elective noncardiac surgery，a prospective, randomized, controlled trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      90 elderly patients undergoing noncardiac surgery were randomly divided into propofol group&#xD;
      and ciprofol group, who were given propofol 1 ~ 2mg/kg or ciprofol 0.2-0.5mg/kg during&#xD;
      anesthesia induction respectively. Systolic blood pressure (SBP), diastolic blood pressure&#xD;
      (DBP), heart rate (HR) and BIS values at various time points during anesthesia induction were&#xD;
      collected. At the same time, rates of injection pain, muscle fasciculation, arrhythmia, cough&#xD;
      and perioperative hepatic and renal functions were compared between the two groups. The&#xD;
      primary outcomes were the fluctuations in hemodynamic parameters during induction. The&#xD;
      secondary outcome were adverse reactions, BIS values and changes of hepatic and renal&#xD;
      functions during induction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemodynamic changes：Systolic blood pressure (SBP)</measure>
    <time_frame>From the beginning of drug administration to 30 minutes after intubation</time_frame>
    <description>Systolic blood pressure (SBP) during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemodynamic changes: Diastolic blood pressure(DBP)</measure>
    <time_frame>From the beginning of drug administration to 30 minutes after intubation</time_frame>
    <description>Diastolic blood pressure(DBP) during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemodynamic changes: Heart rate （HR ）</measure>
    <time_frame>From the beginning of drug administration to 30 minutes after intubation</time_frame>
    <description>Heart rate （HR ）during anesthesia induction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse reactions: injection pain</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>injection pain from propofol or ciprofol intravenous injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse reactions: muscle fasciculation</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>muscle fasciculation induced by propofol or ciprofol intravenous induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse reactions：arrhythmia</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>arrhythmia induced by propofol or ciprofol intravenous induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perioperative hepatic function: Aspartate Aminotransferase ( AST)</measure>
    <time_frame>Before surgery , 1day after operation</time_frame>
    <description>level of Aspartate Aminotransferase ( AST)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perioperative hepatic function: Alanine Aminotransferase ( ALT)</measure>
    <time_frame>Before surgery , 1day after operation</time_frame>
    <description>level of Alanine Aminotransferase ( ALT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perioperative renal function: creatine</measure>
    <time_frame>Before surgery , 1day after operation</time_frame>
    <description>level of creatine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perioperative renal function:Blood Urea Nitrogen</measure>
    <time_frame>Before surgery , 1day after operation</time_frame>
    <description>level of Blood Urea Nitrogen（BUN)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monitoring Depth of Anesthesia</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>BIS values</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>According to grouping，patients were premeditated with injection of Propofol 1-2mg / kg IV . If BIS is ≤ 60, Tracheal intubation was facilitated with cisatracurium 0.2mg/kg a IV and sufentanil 0.3 μ g / kg IV. if BIS is &gt;60, propofol 0.5mg/kg was titrated intravenously, with an interval of more than 1min until the BIS is ≤ 60，and intubation was performed after cisatracurium and sufentanil injected .General anesthesia was maintained with Propofol and remifentanil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ciprofol group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>According to grouping，patients were premeditated with injection of ciprofol 0.2-0.5mg/kg IV. If BIS is ≤ 60, Tracheal intubation was facilitated with cisatracurium 0.2mg/kg a IV and sufentanil 0.3 μ g / kg IV. if BIS is &gt;60, ciprofol 0.1mg/kg was titrated intravenously, with an interval of more than 1min until the BIS is ≤ 60，and intubation was performed after cisatracurium and sufentanil injected .General anesthesia was maintained with Propofol and remifentanil in both groups.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol 1-2mg / kg was for anesthesia induction. Propofol is a hypnotic agent that is used as an induction agent and as a maintenance anaesthetic delivered by continuous i.v. infusion or intermittent i.v. bolus.</description>
    <arm_group_label>propofol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ciprofol</intervention_name>
    <description>Ciprofol 0.2～0.5mg/kg was for anesthesia induction. Ciprofol is an intravenous sedative-hypnotic and a short-acting GABAA receptor agonist. It activates GABAergic neurons by enhancing chloride ion influx. It is used for anesthetic induction and maintenance agents include rapid induction of general anesthesia, rapid return of consciousness, minimal residual effects on the central nervous system and less injection pain.</description>
    <arm_group_label>ciprofol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ASA physical status Ⅰ-Ⅲ&#xD;
&#xD;
          2. Age over 65 years;&#xD;
&#xD;
          3. Body mass index (BMI) 20 ~ 30 kg/m2 ;&#xD;
&#xD;
          4. Elective noncardiac surgery;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The patient or his/her family refused to participate in the clinical trial;&#xD;
&#xD;
          2. Severe heart, lung, liver or kidney dysfunction;&#xD;
&#xD;
          3. Expected difficult airway, requiring awake tracheal intubation;&#xD;
&#xD;
          4. Those who are allergic to the drugs used in this study;&#xD;
&#xD;
          5. Unsuccessful tracheal intubation twice;&#xD;
&#xD;
          6. Patients with mental illness or impaired consciousness;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiumei Song, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Qian fo shan hospitial of shan dong province, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiumei Song, Doctor</last_name>
    <phone>+8613969050425</phone>
    <email>ssm801117@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jinwan Guo, Master</last_name>
    <phone>_+8617686830961</phone>
    <email>guojinwan2010@163.com</email>
  </overall_contact_backup>
  <link>
    <url>http://rs.yiigle.com/CN131073202102/1326216.htm</url>
    <description>Liu J, Wang D , Zuo Y, MI W, Yao S, Yu W. Guidelines on clinical application of ciprofol. Chin J Anesthesiol, 2021,41 (2): 129-132</description>
  </link>
  <reference>
    <citation>Teng Y, Ou M, Wang X, Zhang W, Liu X, Liang Y, Li K, Wang Y, Ouyang W, Weng H, Li J, Yao S, Meng J, Shangguan W, Zuo Y, Zhu T, Liu B, Liu J. Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials. Eur J Pharm Sci. 2021 Sep 1;164:105904. doi: 10.1016/j.ejps.2021.105904. Epub 2021 Jun 8.</citation>
    <PMID>34116176</PMID>
  </reference>
  <reference>
    <citation>Wang X, Wang X, Liu J, Zuo YX, Zhu QM, Wei XC, Zou XH, Luo AL, Zhang FX, Li YL, Zheng H, Li H, Wang S, Wang DX, Guo QL, Liu CM, Wang YT, Zhu ZQ, Wang GY, Ai YQ, Xu MJ. Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative study. Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1607-1617. doi: 10.26355/eurrev_202203_28228.</citation>
    <PMID>35302207</PMID>
  </reference>
  <reference>
    <citation>Qin K, Qin WY, Ming SP, Ma XF, Du XK. Effect of ciprofol on induction and maintenance of general anesthesia in patients undergoing kidney transplantation. Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):5063-5071. doi: 10.26355/eurrev_202207_29292.</citation>
    <PMID>35916802</PMID>
  </reference>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>November 29, 2022</study_first_submitted>
  <study_first_submitted_qc>January 20, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2023</study_first_posted>
  <last_update_submitted>January 20, 2023</last_update_submitted>
  <last_update_submitted_qc>January 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Qianfoshan Hospital</investigator_affiliation>
    <investigator_full_name>Xiumei Song</investigator_full_name>
    <investigator_title>Associate chief physician</investigator_title>
  </responsible_party>
  <keyword>Anesthesia induction</keyword>
  <keyword>Ciprofol</keyword>
  <keyword>propofol</keyword>
  <keyword>Injection pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>We plan to upload and share data with other researchers. Protecting patient privacy when sharing patient-level data from clinical trial</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>study protocol and Informed Consent Form will available before 2024/1/1 Statistical Analysis Plan and Clinical Study Report will available before 2024/6/1</ipd_time_frame>
    <ipd_access_criteria>All registered researchers</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

